Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency. [electronic resource]
Producer: 20201124Description: 106216 p. digitalISSN:- 1878-1705
- Complement C1 Inhibitor Protein -- administration & dosage
- Disease Progression
- Drug Administration Schedule
- Female
- Hereditary Angioedema Types I and II -- diagnosis
- Home Care Services
- Humans
- Injections, Intravenous
- Injections, Subcutaneous
- Male
- Prospective Studies
- Recombinant Proteins -- administration & dosage
- Self Care
- Severity of Illness Index
- Symptom Flare Up
- Treatment Outcome
- Visual Analog Scale
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.